ERYTECH to Present Preclinical Results Supporting Immunotherapy Potential of ERYMMUNE Platform at Two … – Yahoo Finance
|
ERYTECH to Present Preclinical Results Supporting Immunotherapy Potential of ERYMMUNE Platform at Two …
Yahoo Finance These data support the therapeutic strategy of using red blood cells as carriers to induce efficient and antigen-specific immune response for effective cancer immunotherapy, suggesting that this platform has immense potential in cancer immunotherapy … |
